Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-15-081134
Filing Date
2015-11-24
Accepted
2015-11-24 16:26:25
Documents
1
Period of Report
2015-11-24

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 5431
  Complete submission text file 0001104659-15-081134.txt   6756
Mailing Address 45 ROCKEFELLER PLAZA, SUITE 2000 NEW YORK NY 10111
Business Address 45 ROCKEFELLER PLAZA, SUITE 2000 NEW YORK NY 10111 212-203-5072
Axsome Therapeutics, Inc. (Issuer) CIK: 0001579428 (see all company filings)

EIN.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 25 BROADWAY 9TH FLOOR NEW YORK NY 10004
Business Address
Ames Constance (Reporting) CIK: 0001658296 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37635 | Film No.: 151252996